suggests the T4BSS is involved in increased LDs in C. burnetii-infected alveolar macrophages.
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To confirm this finding, we analyzed LD numbers in human macrophage-like cells (THP- LDs in both human and mouse macrophages is species-independent and dependent on the C. The requirement for the C. burnetii T4BSS suggests that one or more C. burnetii T4BSS LDs via effector proteins. For example, the C. trachomatis secreted protein Lda3 localizes to the 1 5 0 LD surface and is involved in LD translocation into the Chlamydia-containing inclusion (21). The Salmonella Typhimurium type 3 secretion system (T3SS) effector protein SseJ esterifies LDs. While C. burnetii effectors might directly target proteins involved in LD formation or LDs 1 5 5 themselves, it is also possible that fission of preexisting LDs, and not de novo formation, is 1 5 6 responsible for increased numbers of LDs (36). As observed in Figure 2A , the LD size in C. fission of the existing LDs. accumulation may also be a host innate immune response. In other diseases, LD accumulation 1 6 2 occurs during the inflammatory response in macrophages in atherosclerotic lesions (37),
leukocytes from joints of patients with inflammatory arthritis (38), and eosinophils in allergic demonstrate that the C. burnetii T4BSS is involved in LD accumulation in both mouse and 1 6 7 human macrophages, the bacterial effector proteins and the specific LD processes involved 1 6 8 remain unknown. Blocking LD formation increases C. burnetii growth. Given our finding that the C. burnetii T4BSS may manipulate host LD accumulation, we
next assessed the importance of LDs during C. burnetii infection. We first blocked LD formation control, triascin C significantly reduced macrophage LDs, with <5 LDs per cell ( Figure 3A ). We To further validate these results, we used CRISPR/Cas-9 to knockout acat-1 ( Figure 3C ), growth. To further deplete both triacylglycerol-and sterol ester-containing LDs, we treated acat-
1 -/-cells with the DGAT1 inhibitor T863, which specifically blocks formation of triacylglycerols wild-type or acat-1 -/-macrophages ( Figure 3D ). C. burnetii growth increased 2-fold in T863- blocking both sterol ester-and triacylglycerol-containing LDs improves C. burnetii growth.
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These studies demonstrate that both pharmaceutical and genetic approaches to blocking
LD formation increases C. burnetii fitness in macrophages. Interestingly, Mahapatra et al.
observed an increase in plin-2 transcript levels after transiently blocking C. burnetii protein
synthesis, suggesting that wild-type C. burnetii downregulates LD formation (28). It is not clear
why inhibiting LD formation is advantageous to C. burnetii. While it is not known if C. burnetii
uses host fatty acids, unesterified free fatty acids or sterols in LD-deficient cells may support C.
burnetii growth. Because blocking LD formation appeared to benefit C. burnetii, we next examined C. ( Figure 4A ). Treatment for 4 days had no effect on axenic bacterial growth, indicating atglistatin
does not directly affect C. burnetii.
We next tested the effect of atglistatin on intracellular bacteria. After atglistatin treatment the number did not significantly increase ( Figure 3A) . Interestingly, C. burnetii intracellular LDs, also showed reduced bacterial growth ( Figure 4C ). Together, these data demonstrate that Our data suggest that LD breakdown is essential for C. burnetii intracellular growth in In addition to serving as a source of free fatty acids and sterols, macrophage LDs are rich reversed by PGE2 suppression with indomethacin (47). In addition, after stimulation with C. inhibitor Piroxicam reversed this downregulation of pro-inflammatory cytokine production (48).
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Thus, while PGE2 appears to play a role in Q fever patients, the relationship between C.
burnetii-induced LDs and PGE2 production is not known. Considering that LD breakdown can response to promote C. burnetii intracellular growth.
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In summary, our data demonstrate that LD homeostasis is important for C. burnetii understand the role of LDs in C. burnetii pathogenesis. 
MATERIALS AND METHODS
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Bacteria and mammalian cells Manassas, VA) and stored as previously described (49). For experiments examining T4BSS- ACCM-2, washed twice with phosphate buffered saline (PBS) and stored as previously described Biologicals, Norcross, GA, USA) at 37°C and 5% CO 2 and human embryonic kidney 293 Generating acat-1 -/-MH-S cell line
The guide RNA sequence 5′TCGCGTCTCCATGGCTGCCC3′ to mouse acat-1 was selected
using the optimized CRISPR design site crispr.mit.edu. Oligonucleotides were synthesized (IDT,
Coralville, IA, USA), annealed, and cloned into the lentiCRISPRv2 plasmid (a gift from Feng To test bacterial sensitivity to atglistatin, ACCM-2 was inoculated at approximately 1x10 5 3 4 2 bacteria/ml with C. burnetii NMII and grown for 3 days as previously described (51). Bacteria inhibitor. After 4 days, bacteria were diluted 1:10 in 2% FBS-RPMI and serial dilutions were was done in duplicate. Statistical analyses were performed using ordinary one-way ANOVA or two-way ANOVA with 
